COMMUNIQUÉS West-GlobeNewswire

ProLynx and Daiichi Sankyo announce the development of technology for half-life extension of small molecules in the eye
29/08/2018
SAN FRANCISCO, Aug. 29, 2018 (GLOBE NEWSWIRE) -- ProLynx and Daiichi Sankyo Company, Limited, announced today the publication of a paper in the journal TVST entitled “A controlled release system for long-acting [...]
MannKind Corporation to Present at Upcoming Conferences
29/08/2018
WESTLAKE VILLAGE, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such [...]
High Hampton Holdings Expands California Network with CaliGold Acquisition -- CFN Media
29/08/2018
SEATTLE, Aug. 29, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
New Data on NOCTIVA™ Presented at the 2018 International Continence Society Meeting
29/08/2018
Data demonstrate meaningful reduction in nocturic episodes, extended first uninterrupted sleep period, and improved quality of life for patients suffering from nocturia due to nocturnal polyuria DUBLIN, Ireland, Aug. 29 [...]
Globus Medical to Exhibit Latest Advancements in MIS Spine Surgery at SMISS Annual Forum
29/08/2018
AUDUBON, Pa., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will feature its ExcelsiusGPS® revolutionary robotic guidance and navigation system along [...]
Albireo to Present at the H.C. Wainwright Global Investment Conference
29/08/2018
BOSTON, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that Ron Cooper, President [...]
ChromaDex to Present at the 7th Annual Liolios Gateway Conference on September 6, 2018
29/08/2018
IRVINE, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age with its flagship ingredient NIAGEN® and [...]
Ultragenyx Announces FDA Accepts Proposal to Submit an NDA for UX007 for the Treatment of Long-Chain Fatty Acid Oxidation Disorders
29/08/2018
NOVATO, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced [...]
Avinger Receives New Patent Covering Pantheris Image-Guided Atherectomy System
29/08/2018
Extensive Intellectual Property Portfolio Now Includes 131 Patents and Applications REDWOOD CITY, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for [...]
Cesca Therapeutics Announces Poster Presentation at the 4th Annual CAR-TCR Summit
29/08/2018
Management Will Also Deliver Spotlight Presentation During the “Tech Slam at the Innovation Hub” RANCHO CORDOVA, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ: KOOL), a market leader in [...]
Cellectar Biosciences to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
29/08/2018
MADISON, Wis., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the [...]
Biodesix Confirms Prognostic Value of VeriStrat Testing in Phase 3 Study of Patients with Advanced Lung Cancer
29/08/2018
The Oncologist Publishes Results of 1,048 Patient Study BOULDER, Colo., Aug. 29, 2018 (GLOBE NEWSWIRE) -- A new study published in The Oncologist demonstrates the objective prognostic value of the Biodesix VeriStrat ® [...]
Cambrex to Present at Upcoming Investor Conferences in September
29/08/2018
EAST RUTHERFORD, N.J., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that [...]
Genocea to Present at Two September Investor Conferences
29/08/2018
CAMBRIDGE, Mass., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing neoantigen cancer vaccines, today announced that Chip Clark, president and chief [...]
Avid Bioservices to Present at Upcoming Investor Conferences
29/08/2018
TUSTIN, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by [...]
Catalyst Pharmaceuticals to Present at Rodman & Renshaw’s 20th Annual Global Investment Conference
29/08/2018
CORAL GABLES, Fla., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with [...]
Endocyte to Present at Wells Fargo Securities 2018 Healthcare Conference
29/08/2018
WEST LAFAYETTE, Ind., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced that the company’s [...]
Iovance Biotherapeutics to Present at Two Investor Conferences in September
29/08/2018
SAN CARLOS, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology [...]
Evolus Receives Acceptance of FDA BLA Resubmission for DWP-450
29/08/2018
Application Designated as Class 2 by U.S. FDA and Assigned February 2, 2019 PDUFA Date IRVINE, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a company dedicated to aesthetic medicine, today [...]

Pages